Skip to content

Amanda Walker

    • 8h-indexImpact measure calculated using publication and citation counts. Updated daily.
    • 236CitationsNumber of citations received by Amanda's publications. Updated daily.

    Other IDs

    Research interests

    Functional ImagingMolecular BiologyImmunotherapyRadiation Oncology

    Co-authors (107)

    • ANTHONY CRASTO
    • Evgeny Denisov
    • Stephen Helms

    Publications (4)

    • A phase II clinical trial of polyethylene glycol-conjugated L-asparaginase in patients with advanced ovarian cancer: Early closure for safety

      • Hays J
      • Kim G
      • Walker A
      • et al.
      N/AReaders
      N/ACitations
    • Molecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer.

      • Alcorn S
      • Walker A
      • Gandhi N
      • et al.
      N/AReaders
      N/ACitations
      Get full text
    • L-asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer.

      • Yu M
      • Henning R
      • Walker A
      • et al.
      N/AReaders
      N/ACitations
      Get full text
    • Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2.

      • Annunziata C
      • Walker A
      • Minasian L
      • et al.
      N/AReaders
      N/ACitations
      Get full text